Table 1.
Clinical, biochemical, hormonal and DXA characteristics of study and control group
| Variable | Study group | Control group | p | ||
| Age (years) | 69.72 ± 7.81 | 68.75 ± 7.074 | 0.218 | ||
| BMI (kg/m2) | 26.21 ± 3.71 | 25.83 ± 2.96 | 0.295 | ||
| Waist (cm) | 86.57 ± 7.70 | 84.58 ± 5.50 | 0.0054* | ||
| Systemic blood pressure (mmHg) | 129.86 ± 7.34 | 124.43 ± 8.22 | <0.0001* | ||
| Diastolic blood pressure (mmHg) | 81.62 ± 6.16 | 77.68 ± 6.16 | <0.0001* | ||
| Fasting glucose (mg/dL) | 91.33 ± 13.53 | 85.99 ± 7.31 | <0.0001* | ||
| Triglycerides (mg/dL) | Mean | 118.29 ± 71.88 | Mean | 102.39 ± 42.64 | |
| Median | 89.00 | Median | 87.00 | 0.442** | |
| HDL-cholesterol (mg/dL) | Mean | 52.49 ± 6.53 | Mean | 50.65 ± 4.78 | |
| Median | 54.00 | Median | 50.00 | <0.001** | |
| tT (ng/mL) | 4.73 ± 1.94 | 5.09 ± 1.70 | 0.244 | ||
| fT (ng/L) | 8.06 ± 4.01 | 9.74 ± 4.20 | < 0.001* | ||
| E2 (pmol/L) | 41.98 ± 17.46 | 48.83 ± 10.74 | 0.002* | ||
| Hip BMD (g/cm2) | 0.82 ± 0.07 | 0.98 ± 0.01 | < 0.001* | ||
| Vertebral BMD (g/cm2) | 0.92 ± 0.07 | 1.16 ± 0.04 | < 0.001* | ||
tT total testosterone, fT free testosterone, E2 estradiol. Values are expressed as mean ± SD;
*
Difference is significant at the 0.01 level.
**
Non-parametric tests were applied and medians were compared.